In addition to being targeted by lncRNAs to regulate autophagy and Wnt/β-catenin in PC, HuR also shows a strong correlation with gemcitabine resistance, which can be used as a marker for the treatment and prognosis of PC 244-246 (Fig. 3). Here, ELAVL1 is linked to pachyonychia congenita.